Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.4K
Overview
44.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conductive Characterization of <i>Pseudomonas aeruginosa</i>-Derived Nanowires for Bioelectrochemical Systems.

ACS applied bio materials·2026
Same author

Estimating population immunity against serotype-two poliomyelitis from the inactivated polio vaccine in routine immunization across 112 countries: A modelling study.

PLoS medicine·2026
Same author

Seroprevalence of dengue virus antibodies among multiple species of non-human primates in Senegal suggests that sylvatic dengue virus is maintained in non-primate reservoirs in this region.

PLoS neglected tropical diseases·2026
Same author

Intramuscular versus intradermal administration of fractional dose inactivated poliovirus vaccine in Mozambique, 2020-2022: an, open-label, non-inferiority, randomised, controlled phase 2 trial.

EClinicalMedicine·2025
Same author

Visualization of the Evolution and Transmission of Circulating Vaccine-Derived Poliovirus (cVDPV) Outbreaks in the African Region.

Bio-protocol·2025
Same author

Three-dose immunogenicity of the type 2 novel oral poliovirus vaccine in a campaign setting in Tajikistan: a follow-up study.

The Lancet. Global health·2025

Related Experiment Video

Updated: Jun 27, 2025

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.3K

The Last Mile in Polio Eradication: Program Challenges and Perseverance.

Rocio Lopez Cavestany1, Martin Eisenhawer1, Ousmane M Diop1

  • 1Polio Eradication, World Health Organization, 1202 Geneva, Switzerland.

Pathogens (Basel, Switzerland)
|April 26, 2024
PubMed
Summary

The Global Polio Eradication Initiative (GPEI) is nearing polio eradication, emphasizing evolving immunization schedules and new vaccine technologies. Continuous re-strategizing is vital for overcoming challenges and preparing for a polio-free future.

Keywords:
Global Polio Eradication Initiativeimmunizationoutbreak responsepoliomyelitisvaccine-derived poliovirus

More Related Videos

Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

8.8K
EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay
11:09

EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay

Published on: September 11, 2016

8.8K

Related Experiment Videos

Last Updated: Jun 27, 2025

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.3K
Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

8.8K
EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay
11:09

EPA Method 1615. Measurement of Enterovirus and Norovirus Occurrence in Water by Culture and RT-qPCR. II. Total Culturable Virus Assay

Published on: September 11, 2016

8.8K

Area of Science:

  • Public Health
  • Vaccinology
  • Infectious Disease Control

Background:

  • The Global Polio Eradication Initiative (GPEI) is in the final stages of eradicating poliovirus.
  • Routine immunization and supplementary vaccination campaigns are crucial for achieving eradication.
  • Surveillance systems are essential for monitoring poliovirus transmission.

Purpose of the Study:

  • To discuss the evolving strategies of the GPEI in the final phase of polio eradication.
  • To highlight the importance of new vaccine technologies in combating poliovirus.
  • To address the need for preparedness in the post-certification era.

Main Methods:

  • Review of current GPEI strategies and challenges.
  • Analysis of novel oral poliovirus vaccine (nOPV) and virus-like particle (VLP) vaccine development.
  • Discussion of future planning for polio eradication and post-certification.

Main Results:

  • Evolving immunization schedules and high-quality campaigns remain critical.
  • Novel vaccines offer sustainable outbreak control and eliminate resurgence risks.
  • Adaptable strategies are necessary to address emerging challenges.

Conclusions:

  • The GPEI requires continuous re-strategizing to achieve final eradication.
  • New vaccine technologies are pivotal for a sustainable polio-free world.
  • Proactive planning for post-certification risks is essential for long-term success.